Blackboard

Blackboard Bio is a stealth-stage biotechnology company focused on developing a next-generation delivery platform for programmable medicines. Spun out of the University of Pennsylvania, the company leverages advanced lipid nanoparticle (LNP) technology and novel ionizable lipids to enable the precise, extrahepatic delivery of genetic payloads such as mRNA, siRNA, and gene-editing tools. By addressing the primary bottleneck in genetic medicine—delivery—Blackboard Bio aims to expand the therapeutic reach of genetic medicines to a wide range of tissues beyond the liver. The company is currently optimizing its proprietary delivery vehicles for applications in oncology and rare genetic disorders.